Dr. Brodkin Bio
Edward S. (Ted) Brodkin, M.D.
Associate Professor of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
Edward S. ("Ted") Brodkin, M.D. is Associate Professor of Psychiatry at the Perelman School of Medicine at the University of Pennsylvania. Dr. Brodkin received his A.B. from Harvard University in 1988 and his M.D. from Harvard Medical School in 1992. He then completed an internship in pediatrics Yale-New Haven Medical Center and a residency in psychiatry at Yale, where he conducted clinical psychopharmacology research in autism spectrum disorders.
He went on to a postdoctoral fellowship in basic neurobiology research at Yale (1995-1998) in the laboratory of Eric Nestler, M.D., Ph.D. where he conducted genetic and neurobiological studies of drug- and stress-responsiveness in rat and mouse models. He then did a second postdoctoral fellowship in genetics research in the Department of Molecular Biology at Princeton University (1998-2002) in the laboratory of Lee M. Silver, Ph.D., where he studied the genetics of aggressive behaviors in mouse models.
Dr. Brodkin's laboratory at University of Pennsylvania is focused on the neurobiology and genetics of social behavior phenotypes in mouse models relevant to autism spectrum disorders (ASD) and relevant to the "negative" symptoms of schizophrenia (SCZ). Social behavior impairments in ASD and SCZ are extremely disabling, and are poorly understood on a neurobiological level. Currently available treatments are grossly inadequate in ameliorating these symptoms.
The Brodkin lab at Penn uses mouse models relevant to ASD and SCZ to elucidate genetic, cellular, and molecular mechanisms of social behavior disruptions. The ultimate goal of this research is to identify novel strategies for treatment of developmental disruptions of social behaviors.
As an M.D., board certified psychiatrist, attending psychiatrist at the Hospital of the University of Pennsylvania, and Director of the Adult Autism Spectrum Program at Penn Medicine, Dr. Brodkin is committed to translating findings from basic research into improved care of patients..
Back to Top